ENTITY Nanjing Medicine

Nanjing Medicine

PulseAugur coverage of Nanjing Medicine — every cluster mentioning Nanjing Medicine across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

0

0 over 90d

TIER MIX · 90D

TOPICS

other 1

TIMELINE

2026-05-21 funding Nanjing Medicine is establishing a merger and acquisition fund with a contribution of up to 450 million yuan to acquire stakes in Daqing Biology and Kejian Technology. source

RECENT · PAGE 1/1 · 1 TOTAL

COMMENTARY · CL_42415 · May 21 · 08:58

BYD denies Maserati acquisition rumors, cites European asset exploration

BYD has officially denied rumors of considering an acquisition of Maserati. The company's executive vice president had previously mentioned exploring high-end European assets, including Maserati, and engaging in discuss…